The drug regulatory body of Mexico (Comisi Federal para la Protecci contra Riesgos Sanitarios) has imposed a penalty of MXN 651, 420 (~Rs 27 Lakh) on the Company for deviation from prescribed guidelines in filing intimation of import of a reference standard for one of the company's APIs. Additionally, the fine was imposed due to an error in the date of the invoice and also name of the reference standard Vs import license.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content